Sasha Latypova is a former pharmaceutical R&D executive with 25 years of experience in clinical trials, clinical technologies, and regulatory approvals. She owned and managed several contract research organizations and worked for more than 60 pharma companies worldwide. She interacted with the FDA as part of a scientific industry consortium on improving cardiac safety assessments in clinical trials.
Follow her at https://twitter.com/sasha_latypova and read more at https://sashalatypova.substack.com